ExploreWatchlistsPricing
  1. JP-listed companies
  2. CHUGAI PHARMACEUTICAL CO., LTD.
  3. Financials
  4. Retained earnings

CHUGAI PHARMACEUTICAL CO., LTD. (4519)

Market cap
¥14.02T
P/E ratio
34.2x
Chugai Pharmaceutical develops and sells prescription medicines in Japan and internationally, with research operations spanning the US, Europe, and Asia.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRetained earnings (Million JPY)YoY (%)
Dec 31, 20251,706,669+6.34%
Dec 31, 20241,604,863+18.74%
Dec 31, 20231,351,597+16.67%
Dec 31, 20221,158,504+24.66%
Dec 31, 2021929,305+26.74%
Dec 31, 2020733,234+18.86%
Dec 31, 2019616,906+19.16%
Dec 31, 2018517,695+11.05%
Dec 31, 2017466,169+9.21%
Dec 31, 2016426,849+4.74%
Dec 31, 2015407,515+8.15%
Dec 31, 2014376,793

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat